DK0455155T3 - Adskillelse af enantiomere af cimaterol - Google Patents

Adskillelse af enantiomere af cimaterol

Info

Publication number
DK0455155T3
DK0455155T3 DK91106774.2T DK91106774T DK0455155T3 DK 0455155 T3 DK0455155 T3 DK 0455155T3 DK 91106774 T DK91106774 T DK 91106774T DK 0455155 T3 DK0455155 T3 DK 0455155T3
Authority
DK
Denmark
Prior art keywords
cimaterol
enantiomers
separation
Prior art date
Application number
DK91106774.2T
Other languages
English (en)
Inventor
Wolfgang Dr Dipl-Chem Resemann
Adolf Duerr
Guenther Prof Dr Engelhardt
John Francis Dr Quirke
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Application granted granted Critical
Publication of DK0455155T3 publication Critical patent/DK0455155T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C07C255/59—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Birds (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK91106774.2T 1990-05-04 1991-04-26 Adskillelse af enantiomere af cimaterol DK0455155T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4014252A DE4014252A1 (de) 1990-05-04 1990-05-04 Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer

Publications (1)

Publication Number Publication Date
DK0455155T3 true DK0455155T3 (da) 1995-11-13

Family

ID=6405664

Family Applications (2)

Application Number Title Priority Date Filing Date
DK91106774.2T DK0455155T3 (da) 1990-05-04 1991-04-26 Adskillelse af enantiomere af cimaterol
DK93117935.2T DK0589488T3 (da) 1990-05-04 1991-04-26 I det væsentlige optisk rent (-)-cimaterol og dens syreadditionssalte samt dens anvendelse som lægemiddel eller vækstfremmer

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK93117935.2T DK0589488T3 (da) 1990-05-04 1991-04-26 I det væsentlige optisk rent (-)-cimaterol og dens syreadditionssalte samt dens anvendelse som lægemiddel eller vækstfremmer

Country Status (27)

Country Link
US (4) US5248695A (da)
EP (2) EP0455155B1 (da)
JP (1) JP2944777B2 (da)
KR (1) KR0183024B1 (da)
AR (1) AR247728A1 (da)
AT (2) ATE124932T1 (da)
AU (1) AU645313B2 (da)
BG (1) BG60743B1 (da)
CA (1) CA2041818C (da)
CZ (1) CZ286389B6 (da)
DE (3) DE4014252A1 (da)
DK (2) DK0455155T3 (da)
ES (2) ES2075255T3 (da)
FI (1) FI109600B (da)
GR (2) GR3017064T3 (da)
HU (1) HU214335B (da)
ID (1) ID966B (da)
IE (2) IE69017B1 (da)
IL (1) IL98030A (da)
NO (1) NO174803B (da)
NZ (1) NZ238032A (da)
PT (1) PT97544B (da)
RU (1) RU2002737C1 (da)
SG (1) SG45439A1 (da)
SK (1) SK279258B6 (da)
TW (1) TW197415B (da)
ZA (1) ZA913337B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4014252A1 (de) * 1990-05-04 1991-11-07 Boehringer Ingelheim Vetmed Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer
GB9107196D0 (en) * 1991-04-05 1991-05-22 Sandoz Ag Improvements in or relating to organic compounds
GB2289842B (en) * 1991-04-05 1996-01-31 Sepracor Inc Improved use of ß2 bronchodilator drugs
EP0892639A4 (en) * 1996-01-29 1999-06-09 Savor Evelyn PROCESS FOR THE TREATMENT OF UNWANTED UTERINE CONTRACTIONS USING OPTICALLY PURE R OR RR ISOMERS OF AGONIST -g (b) -2 ADRENERGIC AGONISTS
EP1787529A3 (en) * 1997-04-30 2009-11-18 Courage Corporation Pty Ltd. Composition and methods using an eutomer
JP2001527545A (ja) 1997-04-30 2001-12-25 ブリッジ ファーマ，インコーポレーテッド ユートマーを使用する組成物および方法
ZA994264B (en) 1998-07-01 2000-01-25 Warner Lambert Co Stereoisomers with high affinity for adrenergic receptors.
US7232837B2 (en) 1999-06-29 2007-06-19 Mcneil-Ppc, Inc. Stereoisomers with high affinity for adrenergic receptors
IL152140A0 (en) * 2000-04-27 2003-05-29 Boehringer Ingelheim Pharma Novel, slow-acting betamimetics, a method for their production and their use as medicaments
US20030162459A1 (en) * 2002-02-27 2003-08-28 Osbon Robert Lindsay Method for producing a nonwoven fabric with enhanced characteristics
US20040235922A1 (en) * 2003-05-15 2004-11-25 Baile Clifton A. Compositions and methods for inducing adipose tissue cell death
PL1663197T3 (pl) * 2003-09-09 2008-09-30 Biogen Idec Int Gmbh Zastosowanie pochodnych kwasu fumarowego do leczenia niewydolności serca oraz astmy
SG124283A1 (en) * 2004-03-24 2006-08-30 Trusted Hub Ltd Document signature method & system
EP1719507B1 (en) * 2005-04-13 2010-07-14 Astion Development A/S Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin
WO2006128180A2 (en) * 2005-05-27 2006-11-30 Children's Medical Center Corporation Methods for the treatment of disease
US20090305225A1 (en) * 2005-06-13 2009-12-10 Galbraith Richard A Inhibition of Creatine Uptake to Promote Weight Loss
CA2891234C (en) 2012-12-03 2017-03-07 Pfizer Inc. Selective androgen receptor modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL136601C (da) * 1967-06-15
US4119710A (en) * 1972-12-18 1978-10-10 Boehringer Ingelheim Gmbh Bronchospasmolytic 1-(p-amino-phenyl)-2-amino-ethanols-(1) and salts
US4407819A (en) * 1980-08-25 1983-10-04 American Cyanamid Company Phenylethanolamine derivatives and acid addition salts thereof for the depression of fat deposition in warm blooded animals
US4814350A (en) * 1986-09-10 1989-03-21 American Cyanamid Company Method of treating diabetes with 5-[1-hydroxy-2-(isopropylamino)ethyl]anthranilonitrile
US4792546A (en) * 1986-12-05 1988-12-20 American Cyanamid Company Method for increasing weight gains and reducing deposition of fat in animals
DE4014252A1 (de) * 1990-05-04 1991-11-07 Boehringer Ingelheim Vetmed Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer

Also Published As

Publication number Publication date
DE59105957D1 (de) 1995-08-17
IL98030A0 (en) 1992-06-21
ZA913337B (en) 1993-01-27
FI912151A (fi) 1991-11-05
NO174803C (da) 1994-07-13
US5248695A (en) 1993-09-28
ATE124932T1 (de) 1995-07-15
CZ286389B6 (cs) 2000-03-15
BG94342A (en) 1994-06-30
KR0183024B1 (ko) 1999-05-15
PT97544B (pt) 1998-08-31
JP2944777B2 (ja) 1999-09-06
AU645313B2 (en) 1994-01-13
US5292753A (en) 1994-03-08
PT97544A (pt) 1992-01-31
ES2109412T3 (es) 1998-01-16
DE4014252A1 (de) 1991-11-07
GR3017064T3 (en) 1995-11-30
IE69017B1 (en) 1996-07-24
US5395957A (en) 1995-03-07
ID966B (id) 1996-09-30
KR910019966A (ko) 1991-12-19
TW197415B (da) 1993-01-01
RU2002737C1 (ru) 1993-11-15
IL98030A (en) 1995-12-31
ES2075255T3 (es) 1995-10-01
DK0589488T3 (da) 1998-05-04
EP0589488B1 (de) 1997-09-17
DE59108853D1 (de) 1997-10-23
HU911502D0 (en) 1991-11-28
HUT60999A (en) 1992-11-30
AU7611191A (en) 1991-11-07
SK279258B6 (sk) 1998-08-05
IE911507A1 (en) 1991-11-06
NO911746D0 (no) 1991-05-03
FI912151A0 (fi) 1991-05-03
AR247728A1 (es) 1995-03-31
EP0589488A1 (de) 1994-03-30
EP0455155A1 (de) 1991-11-06
ATE158277T1 (de) 1997-10-15
CA2041818C (en) 2003-02-11
BG60743B1 (bg) 1996-02-29
HU214335B (hu) 1998-03-02
CS129291A3 (en) 1991-11-12
SG45439A1 (en) 1998-01-16
CA2041818A1 (en) 1991-11-05
NO911746L (no) 1991-11-05
GR3025547T3 (en) 1998-03-31
JPH04225944A (ja) 1992-08-14
EP0455155B1 (de) 1995-07-12
IE80651B1 (en) 1998-11-04
FI109600B (fi) 2002-09-13
US5648386A (en) 1997-07-15
NZ238032A (en) 1996-02-27
NO174803B (no) 1994-04-05

Similar Documents

Publication Publication Date Title
DK0893434T3 (da) Mellemprodukter til fremstilling af oximethere
DK0455155T3 (da) Adskillelse af enantiomere af cimaterol
DK0485170T3 (da) Forbedret smag under anvendelse af menthonkataler
DK660088A (da) Krystallinsk copolymerisat af propylen
DK0468966T3 (da) Syntese af carbonylforbindelser
DK0520984T3 (da) System af strukturelle formlegemer
DK0411084T3 (da) Syntese af hydrocarbylaminer
DK0441478T3 (da) Separeringsfremgangsmåde
DK0488486T3 (da) Fremgangsmåde til fremstilling af pulp
DK0537786T3 (da) Fremstilling af en N-acylaminomethylphosphonsyre
DK360484D0 (da) Modifikation af soja-isolat
DK624184A (da) Fremstilling af 2,3-difluorpyridinforbindelser
DK0563075T3 (da) Fremstilling af peroxidforbindelser
DK0517513T3 (da) Fremstilling af pigmenter
DE69120589T2 (de) Farbtrennungsverfahren
DK0460401T3 (da) Fremstilling af teprodukter
DK0465373T3 (da) Fremgangsmåde til fremstilling af kappa-carragenaner
DE69128442T2 (de) Optisches Trennungsverfahren
DK0494470T3 (da) Fremgangsmåde til ekstrudering af krystallinske aluminosilicater
DE69109910D1 (de) Herstellung von Ethyl-tert.alkyläthern.
DE69118573D1 (de) Optimale zentrifugale Trennung
FI911126A (fi) Organokupraattimenetelmä kefprotsilin valmistamiseksi
DK71590D0 (da) Theemballage af theposetypen
DK0381622T3 (da) Fremgangsmåde til fremstilling af dihalogenbutyraldehyder
DK54790D0 (da) Adskillelsesmetode